Welcome to LookChem.com Sign In|Join Free
  • or
2-cyclohexylpropionic acid, commonly known as ibuprofen, is a nonsteroidal anti-inflammatory drug (NSAID) characterized by its ability to relieve pain and reduce inflammation. It operates by inhibiting the production of chemicals in the body responsible for these symptoms, making it a versatile medication for various conditions.

6051-13-4

Post Buying Request

6051-13-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6051-13-4 Usage

Uses

Used in Pain Relief Applications:
2-cyclohexylpropionic acid is used as an analgesic for conditions such as muscle aches, headaches, and dental pain, providing relief by reducing the inflammation and pain associated with these conditions.
Used in Menstrual Cramps Treatment:
In the healthcare industry, 2-cyclohexylpropionic acid is used as a treatment for menstrual cramps, helping to alleviate the discomfort and pain experienced during menstruation.
Used in Arthritis Management:
2-cyclohexylpropionic acid is utilized as an anti-inflammatory agent in the management of arthritis, reducing the inflammation and pain associated with the condition, thereby improving the quality of life for those affected.
Used in Topical Creams:
In dermatology, 2-cyclohexylpropionic acid is used in topical creams for localized pain and inflammation, offering a targeted approach to symptom management.
Used in Combination Therapy:
2-cyclohexylpropionic acid is often used in combination with other medications to enhance its therapeutic effects, providing a more comprehensive treatment strategy for various conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 6051-13-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,0,5 and 1 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 6051-13:
(6*6)+(5*0)+(4*5)+(3*1)+(2*1)+(1*3)=64
64 % 10 = 4
So 6051-13-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H16O2/c1-7(9(10)11)8-5-3-2-4-6-8/h7-8H,2-6H2,1H3,(H,10,11)

6051-13-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-cyclohexylpropanoic acid

1.2 Other means of identification

Product number -
Other names 2-Cyclohexylpropionic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6051-13-4 SDS

6051-13-4Relevant academic research and scientific papers

Structure-based linker optimization of 6-(2-cyclohexyl-1-alkyl)-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

Li, Daxiong,Zhang, Chunsheng,Ding, Wei,Huang, Siming,Yu, Le,Lu, Nan,Pan, Wenkai,Li, Yiming,De Clercq, Erik,Pannecouque, Christophe,Zhang, Hongbing,Wang, Yueping,He, Yanping,Chen, Fener

supporting information, p. 1020 - 1024 (2020/10/12)

In continuation of our efforts toward the discovery of potent HIV-1 NNRTIs with diverse structures, a series of novel S-DACO analogues of 6-(2-cyclohexyl-1-alkyl)-2-(2-oxo-2-phenyl-ethylsulfanyl)pyrimidin-4(3H)-ones were designed, synthesized and evaluated for their antiviral activities in MT-4 cells. Most of these new compounds showed moderate to good activities against wild type HIV-1 with IC50 values ranging from 7.55 μmol/L to 0.018 μmol/L. Among them, compound 5c was identified as the most promising inhibitor against HIV-1 replication with an IC50 = 0.018 μmol/L, CC50 = 194 μmol/L, and SI = 12791, which was much more potent than the reference drugs NVP and DLV and comparable to AZT and EFV. In addition, 5c also exhibited improved activity against double mutant HIV-1 strain RES056 compared to that of the reference drugs NVP/DLV and DB02. The preliminary structure-activity relationship (SAR) and molecular modeling studies were also discussed, which provides some useful indications for guiding the further rational design of new S-DACO analogues.

Carbonylative Transformation of Allylarenes with CO Surrogates: Tunable Synthesis of 4-Arylbutanoic Acids, 2-Arylbutanoic Acids, and 4-Arylbutanals

Wu, Fu-Peng,Li, Da,Peng, Jin-Bao,Wu, Xiao-Feng

supporting information, p. 5699 - 5703 (2019/08/01)

In this Communication, procedures for the selective synthesis of 4-arylbutanoic acids, 2-arylbutanoic acids, and 4-arylbutanals from the same allylbenzenes have been developed. With formic acid or TFBen as the CO surrogate, reactions proceed selectively and effectively under carbon monoxide gas-free conditions.

1-Aminopyridinium Ylides as Monodentate Directing Groups for sp3 C-H Bond Functionalization

Le, Ky Khac Anh,Nguyen, Hanh,Daugulis, Olafs

supporting information, p. 14728 - 14735 (2019/10/11)

1-Aminopyridinium ylides are efficient directing groups for palladium-catalyzed β-arylation and alkylation of sp3 C-H bonds in carboxylic acid derivatives. The efficiency of these directing groups depends on the substitution at the pyridine moiety. The unsubstituted pyridine-derived ylides allow functionalization of primary C-H bonds, while methylene groups are unreactive in the absence of external ligands. 4-Pyrrolidinopyridine-containing ylides are capable of C-H functionalization in acyclic methylene groups in the absence of external ligands, thus rivaling the efficiency of the aminoquinoline directing group. Preliminary mechanistic studies have been performed. A cyclopalladated intermediate has been isolated and characterized by X-ray crystallography, and its reactivity was studied.

Site-Selective Catalytic Carboxylation of Unsaturated Hydrocarbons with CO2 and Water

Gaydou, Morgane,Moragas, Toni,Juliá-Hernández, Francisco,Martin, Ruben

, p. 12161 - 12164 (2017/09/12)

A catalytic protocol that reliably predicts and controls the site-selective incorporation of CO2 to a wide range of unsaturated hydrocarbons utilizing water as formal hydride source is described. This platform unlocks an opportunity to catalytically repurpose three abundant, orthogonal feedstocks under mild conditions.

COMPOUNDS USEFUL AS MODULATORS OF TRPM8

-

Paragraph 0890, (2016/03/29)

The present invention includes compounds useful as modulators of TRPM8, such as compounds of Formulae (Ia), (Ib) and (Ic), and the subgenus and species thereof; personal products containing those compounds; and the use of those compounds and the personal products, particularly the use of increasing or inducing chemesthetic sensations, such as cooling or cold sensations.

Nickel-catalyzed direct arylation of C(sp3)-H bonds in aliphatic amides via bidentate-chelation assistance

Aihara, Yoshinori,Chatani, Naoto

supporting information, p. 898 - 901 (2014/02/14)

The Ni-catalyzed, direct arylation of C(sp3)-H (methyl and methylene) bonds in aliphatic amides containing an 8-aminoquinoline moiety as a bidentate directing group with aryl halides is described. Deuterium-labeling experiments indicate that the C-H bond cleavage step is fast and reversible. Various nickel complexes including both Ni(II) and Ni(0) show a high catalytic activity. The results of a series of mechanistic experiments indicate that the catalytic reaction does not proceed through a Ni(0)/Ni(II) catalytic cycle, but probably through a Ni(II)/Ni(IV) catalytic cycle.

Facile palladium-catalyzed hydrocarboxylation of olefins without external CO gas

Wang, Yang,Ren, Wenlong,Li, Jingfu,Wang, Haining,Shi, Yian

supporting information, p. 5960 - 5963 (2015/02/19)

An effective Pd-catalyzed hydrocarboxylation of olefins with phenyl formate and formic acid is described. A variety of carboxylic acids are obtained in good yields with high regioselectivities under operationally simple conditions without the use of toxic CO gas.

SUBSTITUTED HETEROCYCLIC COMPOUNDS

-

Page/Page column 92-93, (2010/10/03)

The present invention relates to substituted heterocyclic compounds of Formula I or XI: or pharmaceutically acceptable salts or N-oxides or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are histamine II4 receptor inhibitors useful in the treatment of histamine II4 receptor-associated conditions or diseases or disorders including, for example, inflammatory diseases or disorders, pruritus, and pain.

Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine h2 receptor agonists

Ghorai, Prasanta,Kraus, Anja,Keller, Max,G?tte, Carsten,Igel, Patrick,Schneider, Erich,Schnell, David,Bernhardt, Günther,Dove, Stefan,Zabel, Manfred,Elz, Sigurd,Seifert, Roland,Buschauer, Armin

supporting information; experimental part, p. 7193 - 7204 (2009/10/02)

N1-Aryl(heteroaryl)alkyl-N2-[3-(1H-imidazol-4-yl) propyl]guanidines are potent histamine H2-receptor (H2R) agonists, but their applicability is compromised by the lack of oral bioavailability and CNS penetration. To improve pharmacokinetics, we introduced carbonyl instead of methylene adjacent to the guanidine moiety, decreasing the basicity of the novel H2R agonists by 4-5 orders of magnitude. Some acylguanidines with one phenyl ring were even more potent than their diaryl analogues. As demonstrated by HPLC-MS, the acylguanidines (bioisosteres of the alkylguanidines) were absorbed from the gut of mice and detected in brain. In GTPase assays using recombinant receptors, acylguanidines were more potent at the guinea pig than at the human H2R. At the hH1R and hH3R, the compounds were weak to moderate antagonists or partial agonists. Moreover, potent partial hH4R agonists were identified. Receptor subtype selectivity depends on the imidazolylpropylguanidine moiety (privileged structure), opening an avenue to distinct pharmacological tools including potent H4R agonists.

Palladium-catalyzed asymmetric reduction of racemic allylic esters with formic acid: Effects of phosphine ligands on isomerization of π- allylpalladium intermediates and enantioselectivity

Kawatsura, Motoi,Uozumi, Yasuhiro,Ogasawara, Masamichi,Hayashi, Tamio

, p. 2247 - 2257 (2007/10/03)

A new MOP ligand (lb), (R)-(+)-2-(bis(3- trifluoromethylphenyl)phosphino)-2'-methoxy-1,1'-binaphthyl, was found to be more enantioselective than other MOP ligands for the palladium-catalyzed asymmetric reduction of α,α-disubstituted allylic esters with formic acid. The reduction of DL-2-(1-naphthyl)-3-buten-2-yl benzoate gave 3-(1-naphthyl)- 1-butene of 90% ee. The higher enantioselectivity of lb is ascribed to fast syn-anti isomerization of π-allylpalladium intermediates formed by oxidative addition of allylic ester to a palladium(0) species. The rate of syn-anti isomerization was measured by the magnetization saturation transfer in 1H NMR. (C) 2000 Elsevier Science Ltd.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6051-13-4